Myoscience, a company based in Fremont, California won FDA clearance for its iovera cryoneurolysis system to be used for symptom and pain relief in the knees arising from osteoarthritis. The company’s so-called Focused Cold Therapy delivery system pumps pressurized liquid nitrous oxide (N2O) to the treatment tip, where it is made to turn to a gas and become very cold. The phase change happens in tight location, creating a small and precise treatment area that can be used to create a nerve block that stops the transmission of pain.Treatments are quite fast and result in nearly instantaneous pain reduction thanks to a disruption in the functionality of nerve axons. This happens without damaging the surrounding tissue that surrounds the nerves.Here’s a bit about the study that led to the latest clearance:https://vimeo.com/100351517